Noxopharm Ltd has released a press release.
Market Guidance for Next Six Months
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Noxopharm
- NOX Files Patent Application on Smart Idronoxil
- NOX and Monash Uni Collaboration Receives Federal Grant
- Noxopharm and UNSW combine on stroke project
- NOX researching rare Abscopal Response
- Brain Cancer Study Commences
Later from Noxopharm
- NOX makes strategic commitment to treatment of rare cancers
- St Vincents Cancer Study to Commence-NOX66 and Radiotherapy
- NOX66 confirmed Non-Toxic. Trial Cleared for Full Enrolment
- Idronoxil data provides hope to treat secondary brain cancer
- Noxopharm provides update on NOX66 Clinical Trial Program
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm